Syntheses of the sulfoconjugated isomers of norepinephrine and dopamine, controlled by HPLC with ultraviolet detection.

The physiological significance of sulfoconjugated catecholamines and their involvement in clinical disorders, e.g. hypertension and Parkinsonism, is poorly investigated. For this reason, the sulfoconjugated isomers of dopamine as well as of norepinephrine were synthesized by modified methods. All isomers and their intermediates could be detected by a reversed-phase high-performance liquid chromatography with ultraviolet detection (HPLC-UV) with short retention times and a good reproducibility. Ion-exchange chromatography with an extended column length improved the separation of the reaction products, and the immediate control by HPLC-UV enabled precise cutting of the fractions. The selection of the fractions with the optimum ratios of product/by-product resulted in improved yields and highest purity. All by-products, e.g. dopamine sulfonic acids, were less than 0.04%, as detected by HPLC-UV and, in addition, the contamination by free catecholamines was only 41 x 10(-4)-87 x 10(-4)%, as measured by HPLC with electrochemical detection (HPLC-ED). The purity was further demonstrated in two highly sensitive biological assays: cAMP production in human mononuclear leukocytes and aggregation of human platelets. The sulfoconjugated catecholamines were characterized by melting point, thin-layer chromatography, infrared spectrum, HPLC-UV, elemental analysis, and unequivocally identified by 1H-NMR.

[1]  E. Werle,et al.  Modified syntheses of dopamine-4-sulfate, epinephrine-3-sulfate, and norepinephrine-3-sulfate: determination of the position of the sulfate group by 1H-NMR spectroscopy. , 1988, International journal of sports medicine.

[2]  D. Massaro,et al.  Differences in CuZn superoxide dismutase induction in lungs of neonatal and adult rats. , 1987, The American journal of physiology.

[3]  S. Carrière,et al.  Catecholamine sulfates: end products or metabolic intermediates? , 1987, Life sciences.

[4]  S. Carrière,et al.  The activity of human kidney arylsulfatases A and B towards catecholamine sulfates. , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[5]  E. Knoll,et al.  Plasma free and conjugated catecholamines in clinical disorders , 1986, Life sciences.

[6]  K. Rácz,et al.  Role of sulfate conjugation of catecholamines in blood pressure regulation. , 1986, Federation proceedings.

[7]  M. Feraudi,et al.  Electrochemical detection of catecholamines in urine and plasma after separation with HPLC. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[8]  D. Kerkman,et al.  A FACILE SYNTHESIS OF DOPAMINE-4-SULFATE , 1983 .

[9]  K. Imai,et al.  Determination of catecholamine sulfoconjugate isomers in normal human urine by use of high-performance liquid chromatography with a photochemical detector. , 1983, Analytical biochemistry.

[10]  M. Elchisak.  Determination of dopamine-O-sulfate and norepinephrine-O-sulfate isomers and serotonin-O-sulfate by high-performance liquid chromatography using dual-electrode electrochemical detection. , 1983, Journal of chromatography.

[11]  P. Sever,et al.  Unequivocal synthesis and characterisation of dopamine 3- and 4-O-sulphates. , 1982, Biochemical pharmacology.

[12]  K. Imai,et al.  Improved Synthesis of Sulfoconjugate Isomers of Norepinephrine and Epinephrine, and Separation of All Sulfoconjugates of Catecholamines by Thin-Layer and High-Performance Liquid Chromatography , 1981 .

[13]  J. Roth,et al.  Sulfation of Dopamine and Other Biogenic Amines by Human Brain Phenol Sulfotransferase , 1980, Journal of neurochemistry.

[14]  K. Imai,et al.  High-performance liquid chromatographic determination of dopamine sulfoconjugates in urine after L-dopa administration. , 1979, Journal of chromatography.

[15]  N. Buu,et al.  The direct conversion of dopamine 3-0-sulfate to norepinephrine by dopamine-β-hydroxylase , 1979 .

[16]  K. Imai,et al.  High-performance liquid chromatographic determination of dopamine sulfoconjugates in urine after L-dopa administration. | Article Information | J-GLOBAL , 1979 .

[17]  M. Hoehn,et al.  The separation and identification of dopamine 3-O-sulfate and dopamine 4-O-sulfate in urine of Parkinsonian patients. , 1975, The Journal of pharmacology and experimental therapeutics.

[18]  W. Jenner,et al.  Dopamine 3-O-sulphate, an end product of L-dopa metabolism in Parkinson patients , 1974, Nature.

[19]  R. Bodnaryk,et al.  3-O-hydrosulphato-4-hydroxyphenethylamine (dopamine 3-O-sulphate), a metabolite involved in the sclerotization of insect cuticle. , 1974, The Biochemical journal.

[20]  W. Jenner,et al.  Studies on the sulphation of 3,4-dihydroxyphenylethylamine (dopamine) and related compounds by rat tissues. , 1973, The Biochemical journal.